marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Atossa Therapeutics Financial Ratios 2011-2024 | ATOS
Annual Financial Ratios Atossa Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-8.4 | -3.2 | -7.8 | -1.3 | -0.7 | -0.5 | -0.8 | -0.5 | -0.5 | -1.9 | -3.7 | -11.5 | - |
P/S |
- | - | - | - | - | - | - | - | 4204.3 | 53.5 | 62.7 | 121.7 | - |
EPS |
-0.2 | -0.2 | -0.2 | -2.0 | -2.0 | -5.5 | -11.0 | -2.2 | -8.3 | -0.6 | -0.7 | -0.4 | -0.4 |
EV (Enterprise Value) |
169 M | -19.2 M | 27 M | -1.42 M | 988 K | -2.02 M | 324 K | 1.19 M | 6.18 M | 21.9 M | 34.7 M | 58.6 M | -399 K |
EBITDA per Share |
-0.25 | -0.22 | -0.18 | -1.75 | -2.03 | -2.74 | -7.24 | -36.6 | -79.1 | -87.8 | -120 | -71.4 | - |
EV/EBITDA |
6.5 | 1.0 | 0.0 | 0.4 | 0.1 | -0.0 | -0.3 | -1.7 | -3.2 | -11.5 | - | ||
PEG |
0.45 | 0.09 | 0.14 | -0.09 | -0.01 | -0.01 | -0.01 | -0.01 | -0.05 | -0.15 | 0.05 | 1.46 | - |
P/B |
2.8 | 0.7 | 1.2 | 0.8 | 0.9 | 0.6 | 0.9 | 1.0 | 2.0 | 3.0 | 3.7 | 11.3 | - |
P/CF |
-12.0 | -4.1 | -9.7 | -1.9 | -1.3 | -0.6 | -1.0 | -0.6 | -0.5 | -2.6 | -4.3 | -14.5 | - |
ROE % |
-33.06 | -22.85 | -14.92 | -65.62 | -131.04 | -129.53 | -117.06 | -205.64 | -421.20 | -154.32 | -101.73 | -98.15 | - |
ROA % |
-31.27 | -21.82 | -14.59 | -41.62 | -118.98 | -97.31 | -99.49 | -153.68 | -252.43 | -124.60 | -89.80 | -74.42 | - |
ROCE % |
-34.47 | -23.47 | -14.86 | -65.62 | -131.13 | -129.86 | -103.59 | -234.08 | -340.98 | -128.69 | -101.73 | -97.94 | - |
Current Ratio |
18.4 | 22.2 | 45.2 | 2.7 | 10.8 | 4.0 | 6.4 | 3.1 | 1.7 | 4.1 | 5.3 | 1.2 | - |
DSO |
- | - | - | - | - | - | - | - | - | 206.8 | 80.2 | 107.3 | - |
DIO |
- | - | - | - | - | - | - | - | - | 42.6 | - | - | - |
DPO |
- | - | - | - | - | - | - | - | 2245.1 | 636.8 | 7.1 | 379.4 | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | 249.4 | 80.2 | 107.3 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | -2245.1 | -387.4 | 73.2 | -272.1 | - |
All numbers in USD currency
Quarterly Financial Ratios Atossa Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.06 | -0.05 | -0.05 | - | -0.05 | -0.08 | -0.05 | - | -0.06 | -0.05 | -0.04 | - | -0.04 | -0.06 | -0.04 | - | -0.34 | -0.43 | -0.32 | - | -0.36 | -0.8 | -0.62 | - | -0.64 | -5.08 | -8.48 | - | -2.11 | -7.72 | -5.4 | - | 0.07 | -0.67 | -0.98 | - | -0.15 | -0.11 | -0.13 | - | -0.13 | -0.13 | -0.1 | - | -0.22 | -0.17 | -0.14 | - | -0.1 | -0.1 | -0.09 | - | -0.11 | - | - |
EBITDA per Share |
- | - | -0.06 | - | - | - | -0.06 | - | -0.06 | -0.05 | -0.04 | - | -0.04 | -0.06 | -0.04 | - | -0.34 | -0.43 | -0.32 | - | -0.36 | -0.8 | -0.62 | - | -0.63 | -1.34 | -8.45 | - | -1.89 | -2.93 | -5.27 | - | -0.44 | -0.61 | -0.95 | - | -1.99 | -0.11 | -0.13 | - | -0.12 | -0.12 | -0.09 | - | -0.2 | -0.16 | -0.14 | - | -0.1 | -0.1 | -0.09 | - | -0.11 | - | - |
ROE % |
-30.55 | -27.08 | -28.91 | -21.26 | -27.73 | -27.85 | -23.60 | -15.13 | -18.81 | -16.02 | -15.78 | -11.10 | -23.95 | -33.12 | -42.61 | -38.08 | -63.05 | -75.18 | -116.01 | -111.14 | -148.73 | -161.35 | -153.19 | -105.93 | -137.41 | -131.30 | -116.56 | -180.52 | -173.92 | -135.82 | -159.13 | -124.16 | -239.56 | -361.57 | -390.02 | -288.60 | -322.77 | -241.54 | -191.04 | -93.12 | -126.15 | -125.02 | -115.82 | -75.71 | -97.81 | -86.87 | -85.06 | -65.20 | -146.79 | -206.30 | -183.73 | - | -81.60 | - | - |
ROA % |
-28.72 | -25.75 | -27.78 | -20.60 | -26.92 | -27.12 | -23.03 | -14.78 | -18.41 | -15.73 | -15.57 | -10.97 | -19.12 | -23.63 | -27.92 | -24.15 | -46.82 | -61.35 | -102.36 | -100.91 | -129.15 | -134.71 | -119.94 | -79.58 | -106.33 | -104.85 | -96.96 | -153.43 | -148.49 | -116.79 | -130.90 | -92.78 | -161.95 | -236.05 | -244.87 | -172.96 | -200.55 | -158.98 | -135.70 | -75.19 | -104.35 | -105.92 | -100.33 | -66.84 | -83.59 | -71.18 | -66.78 | -49.43 | -90.86 | -115.54 | -98.43 | - | -41.43 | - | - |
ROCE % |
-33.27 | -32.20 | -30.77 | -21.30 | -27.92 | -26.95 | -24.58 | -15.20 | -18.85 | -15.87 | -15.67 | -11.04 | -23.95 | -33.22 | -42.85 | -38.21 | -63.28 | -75.44 | -116.33 | -111.35 | -148.94 | -161.46 | -153.13 | -105.93 | -135.56 | -127.60 | -107.88 | -81.51 | -131.83 | -152.52 | -180.80 | -181.08 | -283.78 | -336.16 | -365.28 | -274.90 | -309.06 | -240.53 | -189.35 | -93.10 | -126.13 | -125.00 | -115.81 | -75.71 | -97.65 | -86.57 | -84.72 | -64.99 | -146.68 | -206.44 | -183.91 | - | -81.69 | - | - |
Current Ratio |
13.7 | 15.1 | 17.1 | 18.4 | 29.5 | 31.1 | 39.5 | 22.2 | 44.2 | 35.4 | 59.2 | 45.2 | 85.3 | - | - | 2.7 | 2.7 | 23.4 | 46.8 | 10.9 | 10.9 | 10.9 | 10.9 | 4.0 | 4.0 | 4.0 | 4.0 | - | - | - | - | 4.0 | - | - | - | 2.5 | 1.9 | 1.8 | 1.8 | 5.2 | 5.2 | 5.2 | 5.2 | 8.5 | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4356.2 | 2753.3 | 826.5 | - | 165.7 | 38.9 | 70.1 | - | 122.4 | 57.9 | 119.2 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 39.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 237.1 | - | - | - | - | - | - | - | 873.0 | 52.9 | 53.4 | - | 691.6 | 349.9 | 1897.8 | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 39.6 | - | - | - | 4356.2 | 2753.3 | 826.5 | - | 165.7 | 38.9 | 70.1 | - | 122.4 | 57.9 | 119.2 | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -197.5 | - | - | - | 4356.2 | 2753.3 | 826.5 | - | -707.3 | -14.0 | 16.7 | - | -569.2 | -292.0 | -1778.7 | - | - | - | - |
All numbers in USD currency